Roberto Pecoits‐Filho

Author

Pontifícia Universidade Católica do Paraná ORCID

Also Known As

Antonio Lopes, Bruce M Robinson, Bruno Paolino, Christophe Pascal, Filho, Roberto Pecoits, Jochen G. Raimann, Mihran Naljayan, Pascal Morel, Paul Muntner, Pecoit-Filho, Roberto

749

Publications

27.2K

Citations

H-Index

151

Concepts

All Affiliations

Pontifícia Universidade Católica do Paraná Arbor Research Collaborative for Health Karolinska Institutet The University of Sydney University College London

About

Roberto Pecoits‐Filho is an author at Pontifícia Universidade Católica do Paraná specializing in medicine, chronic kidney disease, and nephrology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	35	70	5.4K
2	Public Health	15	23	1.6K
3	Health Sciences	11	13	1.2K
4	Education	1	1	15
5	Allergy	1	1	52

Roberto Pecoits‐Filho

225

Publications

16K

Citations

H-Index

Page 1

	Year	Citations
KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease Alfred K. Cheung, Tara I. Chang, William C. Cushman, Kidney International	2021	1.3K
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial Hiddo J.L. Heerspink, Hans‐Henrik Parving, Dennis L. Andress, The Lancet UrologyRenal DiseaseRenal EventsRenal FunctionDiabetes	2019	589
Serum Albumin, C-Reactive Protein, Interleukin 6, and Fetuin A as Predictors of Malnutrition, Cardiovascular Disease, and Mortality in Patients With ESRD Hirokazu Honda, Abdul Rashid Qureshi, Olof Heimbürger, American Journal of Kidney Diseases MalnutritionMetabolic SyndromeNutritionSerum AlbuminCardiovascular Disease	2005	518
Iron management in chronic kidney disease: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference Iain C. Macdougall, Andreas J. Bircher, Kai‐Uwe Eckardt, Kidney International	2016	468
Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference Catherine M. Clase, Juan Jesús Carrero, David H. Ellison, Kidney International	2019	453
Associations between circulating inflammatory markers and residual renal function in CRF patients Roberto Pecoits‐Filho, Olof Heimbürger, Peter Bárány, American Journal of Kidney Diseases InflammationGlomerular DiseaseHemodialysisUrologyRenal Function	2003	440
Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference Andrew A. House, Christoph Wanner, Mark J. Sarnak, Kidney International	2019	413
Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment Roberto Pecoits‐Filho Nephrology Dialysis Transplantation	2002	394
A pre-specified analysis of the DAPA-CKD trial demonstrates the effects of dapagliflozin on major adverse kidney events in patients with IgA nephropathy David C. Wheeler, Robert D. Toto, Bergur V. Stefánsson, Kidney International	2021	369
Executive summary of the KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease Alfred K. Cheung, Tara I. Chang, William C. Cushman, Kidney International HypertensionPressure MeasurementRenal PathologyRenal InflammationKidney Disease	2021	316

Page 1